Literature DB >> 19673687

Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells.

Takato Takenouchi1, Shuei Sugama, Yoshifumi Iwamaru, Makoto Hashimoto, Hiroshi Kitani.   

Abstract

IL-1beta is one of the most potent proinflammatory cytokines. It is primarily released from activated microglia in the brain, and is also implicated in the induction and progression of pathogenesis in various neurodegenerative disorders. Therefore, to clarify the regulatory or modulatory mechanisms for maturation and release of IL-1beta from microglia may provide therapeutic clues for neuroinflammatory/neurodegenerative diseases. IL-1beta lacks a secretory signal sequence, and thus is not transported through the classical cndoplasmic reticulum/ Golgi-mediated pathway. Although the mechanisms for the release of mature IL-1beta still remain controversial, emerging evidence suggests the pivotal roles of the P2X7 receptor (P2X7R), one of the ionotropic P2X receptors for extracellular ATP, in the release of this cytokine. Here, we review the current studies regarding the modulatory mechanisms of P2X7R-dependent maturation and the release of IL-1beta from microglial cells, focusing on the novel roles of lysophospholipids in this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673687     DOI: 10.1615/critrevimmunol.v29.i4.40

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  30 in total

1.  Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats.

Authors:  Dong Zhou; Meng-Ling Chen; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  Microglial activation in stroke: therapeutic targets.

Authors:  Midori A Yenari; Tiina M Kauppinen; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

3.  P2X7 receptor activation induces inflammatory responses in salivary gland epithelium.

Authors:  Lucas T Woods; Jean M Camden; Josef M Batek; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-08       Impact factor: 4.249

Review 4.  Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles.

Authors:  Xiaoming Hu; Anthony K F Liou; Rehana K Leak; Mingyue Xu; Chengrui An; Jun Suenaga; Yejie Shi; Yanqin Gao; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2014-06-09       Impact factor: 11.685

5.  Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations.

Authors:  Wolfgang Nörenberg; Christoph Hempel; Nicole Urban; Helga Sobottka; Peter Illes; Michael Schaefer
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

Review 6.  P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.

Authors:  Gary A Weisman; Jean M Camden; Troy S Peterson; Deepa Ajit; Lucas T Woods; Laurie Erb
Journal:  Mol Neurobiol       Date:  2012-04-01       Impact factor: 5.590

7.  Establishment of c-myc-immortalized Kupffer cell line from a C57BL/6 mouse strain.

Authors:  Hiroshi Kitani; Chisato Sakuma; Takato Takenouchi; Mitsuru Sato; Miyako Yoshioka; Noriko Yamanaka
Journal:  Results Immunol       Date:  2014-08-23

8.  P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.

Authors:  Daniel Freire; Rachel E Reyes; Ared Baghram; Daryl L Davies; Liana Asatryan
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-23       Impact factor: 4.147

9.  P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus.

Authors:  Ji-Eun Kim; Hea Jin Ryu; Seong-Il Yeo; Tae-Cheon Kang
Journal:  J Neuroinflammation       Date:  2010-10-12       Impact factor: 8.322

Review 10.  P2Y receptors in Alzheimer's disease.

Authors:  Laurie Erb; Chen Cao; Deepa Ajit; Gary A Weisman
Journal:  Biol Cell       Date:  2014-10-13       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.